Sylvie Petitjean

1.1k total citations
26 papers, 766 citations indexed

About

Sylvie Petitjean is a scholar working on Epidemiology, Clinical Psychology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sylvie Petitjean has authored 26 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 9 papers in Clinical Psychology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sylvie Petitjean's work include Substance Abuse Treatment and Outcomes (13 papers), Opioid Use Disorder Treatment (9 papers) and Mental Health Treatment and Access (4 papers). Sylvie Petitjean is often cited by papers focused on Substance Abuse Treatment and Outcomes (13 papers), Opioid Use Disorder Treatment (9 papers) and Mental Health Treatment and Access (4 papers). Sylvie Petitjean collaborates with scholars based in Switzerland, Germany and France. Sylvie Petitjean's co-authors include Gerhard A. Wiesbeck, D Ladewig, Kenneth M. Dürsteler‐MacFarland, Jean‐Jacques Déglon, C. Uehlinger, Marc Walter, Rudolf Stohler, Christoph Meier, Marc Vogel and R. Amrein and has published in prestigious journals such as Clinical Infectious Diseases, International Journal of Environmental Research and Public Health and Drug and Alcohol Dependence.

In The Last Decade

Sylvie Petitjean

26 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Petitjean Switzerland 17 340 276 165 117 98 26 766
Robrina Walker United States 17 317 0.9× 202 0.7× 183 1.1× 118 1.0× 134 1.4× 55 825
Azarakhsh Mokri Iran 19 537 1.6× 341 1.2× 202 1.2× 96 0.8× 135 1.4× 54 1.2k
Michael J. Mancino United States 15 217 0.6× 199 0.7× 101 0.6× 76 0.6× 100 1.0× 40 659
Hamid Ghodse United Kingdom 18 298 0.9× 206 0.7× 287 1.7× 94 0.8× 82 0.8× 69 909
Shalini Arunogiri Australia 13 318 0.9× 299 1.1× 312 1.9× 114 1.0× 136 1.4× 74 940
John Schmittner United States 14 239 0.7× 205 0.7× 76 0.5× 61 0.5× 82 0.8× 25 687
Jonathan Krejci United States 9 234 0.7× 304 1.1× 168 1.0× 65 0.6× 76 0.8× 13 660
Mark A. Belding United States 13 386 1.1× 175 0.6× 175 1.1× 79 0.7× 49 0.5× 19 577
Michael Varenbut Canada 18 392 1.2× 480 1.7× 91 0.6× 70 0.6× 133 1.4× 29 867
David Heller United States 11 191 0.6× 179 0.6× 154 0.9× 201 1.7× 122 1.2× 15 706

Countries citing papers authored by Sylvie Petitjean

Since Specialization
Citations

This map shows the geographic impact of Sylvie Petitjean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Petitjean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Petitjean more than expected).

Fields of papers citing papers by Sylvie Petitjean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Petitjean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Petitjean. The network helps show where Sylvie Petitjean may publish in the future.

Co-authorship network of co-authors of Sylvie Petitjean

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Petitjean. A scholar is included among the top collaborators of Sylvie Petitjean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Petitjean. Sylvie Petitjean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hadjar, Andreas, et al.. (2021). A Typical Case Report: Internet Gaming Disorder Psychotherapy Treatment in Private Practice. International Journal of Environmental Research and Public Health. 18(4). 2083–2083. 5 indexed citations
2.
Petitjean, Sylvie, et al.. (2021). Shopping addiction: A brief review.. Practice Innovations. 6(3). 199–207. 29 indexed citations
3.
Vogel, Marc, et al.. (2017). Patients with non‐substance‐related disorders report a similar profile of childhood trauma experiences compared to heroin‐dependent patients. American Journal on Addictions. 26(3). 215–220. 14 indexed citations
4.
Huber, Christian G., Sylvie Petitjean, Gerhard A. Wiesbeck, et al.. (2017). Effect of Door-Locking Policy on Inpatient Treatment of Substance Use and Dual Disorders. European Addiction Research. 23(2). 87–96. 13 indexed citations
5.
Walter, Marc, Sylvie Petitjean, Gerhard A. Wiesbeck, et al.. (2015). Psychosoziale Behandlungen bei Suchterkrankungen – Suchtspezifische Psychotherapieformen und ihre Wirksamkeit. Fortschritte der Neurologie · Psychiatrie. 83(4). 201–210. 7 indexed citations
6.
Vogel, Marc, Kenneth M. Dürsteler‐MacFarland, Urs Gerhard, et al.. (2014). Association between methadone dose and concomitant cocaine use in methadone maintenance treatment: a register-based study. Substance Abuse Treatment Prevention and Policy. 9(1). 46–46. 22 indexed citations
7.
Petitjean, Sylvie, Kenneth M. Dürsteler‐MacFarland, Johannes Strasser, et al.. (2014). A randomized, controlled trial of combined cognitive-behavioral therapy plus prize-based contingency management for cocaine dependence. Drug and Alcohol Dependence. 145. 94–100. 25 indexed citations
8.
Wurst, Friedrich Martin, Gregory E. Skipper, Manfred Wolfersdorf, et al.. (2013). How therapists react to patient's suicide: findings and consequences for health care professionals' wellbeing. General Hospital Psychiatry. 35(5). 565–570. 32 indexed citations
9.
Petitjean, Sylvie, et al.. (2012). Cognitive behavioral smoking cessation during alcohol detoxification treatment: A randomized, controlled trial. Drug and Alcohol Dependence. 126(3). 279–285. 16 indexed citations
10.
Dürsteler‐MacFarland, Kenneth M., et al.. (2012). A Randomized, Controlled, Pilot Trial of Methylphenidate and Cognitive-Behavioral Group Therapy for Cocaine Dependence in Heroin Prescription. Journal of Clinical Psychopharmacology. 33(1). 104–108. 31 indexed citations
11.
Dürsteler‐MacFarland, Kenneth M., Marc Vogel, Gerhard A. Wiesbeck, & Sylvie Petitjean. (2011). There is no age limit for methadone: a retrospective cohort study. Substance Abuse Treatment Prevention and Policy. 6(1). 9–9. 38 indexed citations
12.
Wurst, Friedrich Martin, Sylvie Petitjean, Sebastian Euler, et al.. (2010). Patient Suicide: A Survey of Therapists' Reactions. Suicide and Life-Threatening Behavior. 40(4). 328–336. 37 indexed citations
13.
Petitjean, Sylvie, D Ladewig, Christoph Meier, R. Amrein, & Gerhard A. Wiesbeck. (2007). Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies. International Clinical Psychopharmacology. 22(5). 292–298. 92 indexed citations
14.
Petitjean, Sylvie, et al.. (2006). THE IMPACT OF SELF-HELP GROUP ATTENDANCE ON RELAPSE RATES AFTER ALCOHOL DETOXIFICATION IN A CONTROLLED STUDY. Alcohol and Alcoholism. 42(2). 108–112. 24 indexed citations
15.
Wiesbeck, Gerhard A., Kenneth M. Dürsteler‐MacFarland, Friedrich Martin Wurst, et al.. (2006). GENETIC STUDY: No association of dopamine receptor sensitivity in vivo with genetic predisposition for alcoholism and DRD2/DRD3 gene polymorphisms in alcohol dependence. Addiction Biology. 11(1). 72–75. 19 indexed citations
16.
Petitjean, Sylvie, et al.. (2001). Double-blind randomized trial of buprenorphine and methadone in opiate dependence. Drug and Alcohol Dependence. 62(1). 97–104. 119 indexed citations
17.
Stohler, Rudolf, et al.. (2000). A Comparison of Heroin Chasers with Heroin Injectors in Switzerland<sup>1</sup>. European Addiction Research. 6(3). 154–159. 11 indexed citations
18.
Ladewig, D & Sylvie Petitjean. (1999). Drogenentzugstherapien. Der Internist. 40(6). 624–627. 1 indexed citations
19.
Uehlinger, C., et al.. (1998). Comparison of Buprenorphine and Methadone in the Treatment of Opioid Dependence. European Addiction Research. 4(Suppl. 1). 13–18. 60 indexed citations
20.
Petitjean, Sylvie, M. Assicot, & Claude Bohuon. (1994). Étude de l'immunoréactivité calcitonin-likeau cours des processus infectieux. Immuno-analyse & Biologie Spécialisée. 9(5). 302–307. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robrina Walker Breakdown of academic impact, for papers by Azarakhsh Mokri Breakdown of academic impact, for papers by Michael J. Mancino Breakdown of academic impact, for papers by Hamid Ghodse Breakdown of academic impact, for papers by Shalini Arunogiri Breakdown of academic impact, for papers by John Schmittner Breakdown of academic impact, for papers by Jonathan Krejci Breakdown of academic impact, for papers by Mark A. Belding Breakdown of academic impact, for papers by Michael Varenbut Breakdown of academic impact, for papers by David Heller
Rankless by CCL
2026